business

Cytokinetics stock rating reaffirmed at Outperform by RBC Capital

Investing.com · Jun 17, 2026, 12:21 PM · Also reported by 2 other sources

Read full story on Investing.com → More top stories

Also covered by

Yahoo Finance Bernstein Assigns Outperform Rating to Celsius Holdings (CELH) Yahoo Finance Leerink Upholds Outperform Rating for Crinetics Pharmaceuticals (CRNX)

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Cytokinetics stock rating reaffirmed at Outperform by RBC Capital

Also covered by

More in business